Picture of Lineage Cell Therapeutics logo

LCTX — Lineage Cell Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million




BRIEF-Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million


Aug 06 (Reuters) - Lineage Cell Therapeutics Q2 operating expenses USD 9.992 million.

  • Q2 net income USD 1.544 million

Recent news on Lineage Cell Therapeutics

See all news